Drugs / melarsoprol
melarsoprol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00330148 | Mar 2001 → Jun 2004 | human African trypanosomiasis | Epicentre | Terminated | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | melarsoprol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00330148 ↗ |
| Known as | Mel b | ChEMBL registry synonym — accepted as the source's own label CHEMBL166 ↗ |
| Known as | RP 3854 | ChEMBL registry synonym — accepted as the source's own label CHEMBL166 ↗ |
| Modality | Small molecule | — CHEMBL166 ↗ |
| Route | Intravenous | “IV melarsoprol 1.8 mg/kg/day” NCT00330148 ↗ |